Human Intestinal Epithelial Cells Release Antiviral Factors That Inhibit HIV Infection of Macrophages.

Le Guo, Xi-Qiu Xu, Li Zhou, Run-Hong Zhou, Xu Wang, Jie-Liang Li, Jin-Biao Liu, Hang Liu, Biao Zhang, Wen-Zhe Ho
Author Information
  1. Le Guo: Wuhan University School of Basic Medical Sciences, Wuhan, China.
  2. Xi-Qiu Xu: Wuhan University School of Basic Medical Sciences, Wuhan, China.
  3. Li Zhou: Wuhan University School of Basic Medical Sciences, Wuhan, China.
  4. Run-Hong Zhou: Wuhan University School of Basic Medical Sciences, Wuhan, China.
  5. Xu Wang: Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
  6. Jie-Liang Li: Department of Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
  7. Jin-Biao Liu: Wuhan University School of Basic Medical Sciences, Wuhan, China.
  8. Hang Liu: Wuhan University School of Basic Medical Sciences, Wuhan, China.
  9. Biao Zhang: Wuhan University School of Basic Medical Sciences, Wuhan, China.
  10. Wen-Zhe Ho: Wuhan University School of Basic Medical Sciences, Wuhan, China.

Abstract

As a rich source of CD4 T cells and macrophages, the gastrointestinal (GI) tract is a major target site for HIV infection. The interplay between GI-resident macrophages and intestinal epithelial cells (IECs) constitutes an important element of GI innate immunity against pathogens. In this study, we investigated whether human IECs have the ability to produce antiviral factors that can inhibit HIV infection of macrophages. We demonstrated that IECs possess functional toll-like receptor 3 (TLR3), the activation of which resulted in induction of key interferon (IFN) regulatory factors (IRF3 and IRF7), IFN-β, IFN-λ, and CC chemokines (MIP-1α, MIP-1β, RANTES), the ligands of HIV entry co-receptor CCR5. In addition, TLR3-activated IECs release exosomes that contained the anti-HIV factors, including IFN-stimulated genes (ISGs: ISG15, ISG56, MxB, OAS-1, GBP5, and Viperin) and HIV restriction miRNAs (miRNA-17, miRNA-20, miRNA-28, miRNA-29 family members, and miRNA-125b). Importantly, treatment of macrophages with supernatant (SN) from the activated IEC cultures inhibited HIV replication. Further studies showed that IEC SN could also induce the expression of antiviral ISGs and cellular HIV restriction factors (Tetherin and APOBEC3G/3F) in HIV-infected macrophages. These findings indicated that IECs might act as an important element in GI innate immunity against HIV infection/replication.

Keywords

References

  1. J Gastroenterol Hepatol. 2016 Oct;31(10 ):1694-1699 [PMID: 27061439]
  2. Blood Cells Mol Dis. 2005 Jul-Aug;35(1):11-6 [PMID: 15893486]
  3. Immunology. 2010 Sep;131(1):40-9 [PMID: 20636339]
  4. J Gastroenterol. 2000;35(11):805-14 [PMID: 11085489]
  5. J Neurosci Res. 2012 Feb;90(2):399-406 [PMID: 22057682]
  6. Cell Host Microbe. 2014 Dec 10;16(6):711-21 [PMID: 25467409]
  7. J Immunol. 2005 Apr 1;174(7):4289-94 [PMID: 15778392]
  8. AIDS. 2013 Sep 10;27(14):2201-6 [PMID: 24005480]
  9. J Clin Invest. 2014 Jul;124(7):2841-3 [PMID: 24983425]
  10. Cell. 2009 Oct 30;139(3):499-511 [PMID: 19879838]
  11. Biol Reprod. 2008 Oct;79(4):766-75 [PMID: 18596219]
  12. Nat Cell Biol. 2007 Jun;9(6):654-9 [PMID: 17486113]
  13. Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1440-5 [PMID: 16434471]
  14. Immunity. 2006 Sep;25(3):349-60 [PMID: 16979567]
  15. Retrovirology. 2010 Jun 22;7:54 [PMID: 20569472]
  16. Immunology. 2005 Aug;115(4):565-74 [PMID: 16011525]
  17. Am J Reprod Immunol. 2014 Jun;71(6):537-42 [PMID: 24689691]
  18. Nat Immunol. 2006 Feb;7(2):131-7 [PMID: 16424890]
  19. Nat Med. 2007 Oct;13(10):1241-7 [PMID: 17906637]
  20. Neuroscience. 2009 Mar 17;159(2):629-37 [PMID: 19166911]
  21. FASEB J. 2016 Dec;30(12 ):4132-4140 [PMID: 27605546]
  22. J Immunol. 2010 Apr 1;184(7):3648-55 [PMID: 20208001]
  23. Cell Host Microbe. 2016 Apr 13;19(4):504-14 [PMID: 26996307]
  24. Nat Rev Immunol. 2014 Mar;14(3):141-53 [PMID: 24566914]
  25. Cell Host Microbe. 2013 Oct 16;14(4):398-410 [PMID: 24055605]
  26. Blood. 2009 Jan 15;113(3):671-4 [PMID: 19015395]
  27. Nat Rev Immunol. 2010 Feb;10 (2):131-44 [PMID: 20098461]
  28. Gastroenterology. 2009 May;136(6):1965-78 [PMID: 19462506]
  29. Glia. 2011 Jan;59(1):58-67 [PMID: 20878770]
  30. Nat Rev Immunol. 2008 Jun;8(6):411-20 [PMID: 18469830]
  31. J Leukoc Biol. 2014 Jan;95(1):71-81 [PMID: 24158961]
  32. J Virol. 2015 Jul;89(13):6575-84 [PMID: 25855743]
  33. Infect Immun. 2000 Dec;68(12):7010-7 [PMID: 11083826]
  34. J Virol. 2010 May;84(10 ):5250-9 [PMID: 20219927]
  35. Blood. 2013 Apr 11;121(15):2934-42 [PMID: 23401273]
  36. J Leukoc Biol. 2013 Aug;94(2):337-41 [PMID: 23744645]
  37. J Cell Biol. 2012 Jan 23;196(2):213-21 [PMID: 22249292]
  38. Antiviral Res. 2016 Oct;134:167-171 [PMID: 27496004]
  39. AIDS. 2007 Jan 2;21(1):13-22 [PMID: 17148963]
  40. Nature. 2013 Oct 24;502(7472):559-62 [PMID: 24048477]
  41. Trends Immunol. 2005 Jul;26(7):396-401 [PMID: 15922665]
  42. Science. 2007 Mar 16;315(5818):1579-82 [PMID: 17322031]
  43. Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17633-8 [PMID: 20861448]
  44. Nat Med. 2007 May;13(5):552-9 [PMID: 17479101]
  45. Blood Cells Mol Dis. 2005 Sep-Oct;35(2):169-73 [PMID: 16081306]
  46. J Immunol. 2006 Jun 15;176(12):7335-45 [PMID: 16751377]
  47. Immunol Rev. 2014 Jul;260(1):102-17 [PMID: 24942685]
  48. Nat Immunol. 2015 Jun;16(6):554-62 [PMID: 25988887]
  49. Nat Immunol. 2013 Aug;14(8):793-803 [PMID: 23832071]
  50. Pathog Dis. 2014 Jul;71(2):109-20 [PMID: 24449527]
  51. Genomics Proteomics Bioinformatics. 2015 Feb;13(1):17-24 [PMID: 25724326]
  52. J Virol. 2014 Feb;88(4):2025-34 [PMID: 24307588]
  53. PLoS One. 2012;7(4):e35902 [PMID: 22558263]
  54. ISRN AIDS. 2013 Aug 12;2013:954806 [PMID: 24052891]
  55. Innate Immun. 2013;19(2):184-92 [PMID: 23035017]
  56. Cell. 2006 Feb 24;124(4):767-82 [PMID: 16497587]
  57. Nat Cell Biol. 2006 Dec;8(12):1327-36 [PMID: 17128265]
  58. J Interferon Cytokine Res. 2013 Feb;33(2):90-5 [PMID: 23276142]
  59. J Clin Invest. 2016 Apr 1;126(4):1181-9 [PMID: 27035809]
  60. Nat Cell Biol. 2009 Sep;11(9):1143-9 [PMID: 19684575]
  61. Nat Rev Immunol. 2008 Jul;8(7):559-68 [PMID: 18575461]
  62. Viral Immunol. 2002;15(1):95-119 [PMID: 11952150]
  63. In Vitro Cell Dev Biol Anim. 1996 Jun;32(6):315-7 [PMID: 8842743]
  64. J Immunol. 2007 Sep 15;179(6):3434-42 [PMID: 17785777]
  65. J Cell Biol. 1978 Jun;77(3):853-80 [PMID: 567227]
  66. J Neurovirol. 2014 Jun;20(3):199-208 [PMID: 24578033]
  67. Nat Med. 2002 Feb;8(2):150-6 [PMID: 11821899]
  68. Front Microbiol. 2016 Aug 15;7:1274 [PMID: 27574520]
  69. Mol Cell. 2009 Jun 26;34(6):696-709 [PMID: 19560422]
  70. J Allergy Clin Immunol. 2010 May;125(5):985-92 [PMID: 20392481]
  71. Biochem Soc Trans. 2007 Dec;35(Pt 6):1468-72 [PMID: 18031247]

Grants

  1. R21 DA040329/NIDA NIH HHS
  2. R21 DA042373/NIDA NIH HHS
  3. R21 MH109385/NIMH NIH HHS
  4. R01 DA022177/NIDA NIH HHS
  5. R01 DA041302/NIDA NIH HHS

MeSH Term

Aged
Cell Line
Chemokines, CC
Epithelial Cells
Exosomes
HIV Infections
HIV-1
Humans
Immunity, Innate
Interferon Regulatory Factors
Interferons
Intestinal Mucosa
Macrophages
Male
Toll-Like Receptor 3

Chemicals

Chemokines, CC
Interferon Regulatory Factors
TLR3 protein, human
Toll-Like Receptor 3
Interferons

Word Cloud

Created with Highcharts 10.0.0HIVmacrophagesIECsfactorscellsGIinfectionintestinalepithelialimportantelementinnateimmunityhumanantiviraltoll-likereceptor3exosomesIFN-stimulatedgenesrestrictionSNIECrichsourceCD4TgastrointestinaltractmajortargetsiteinterplayGI-residentconstitutespathogensstudyinvestigatedwhetherabilityproducecaninhibitdemonstratedpossessfunctionalTLR3activationresultedinductionkeyinterferonIFNregulatoryIRF3IRF7IFN-βIFN-λCCchemokinesMIP-1αMIP-1βRANTESligandsentryco-receptorCCR5additionTLR3-activatedreleasecontainedanti-HIVincludingISGs:ISG15ISG56MxBOAS-1GBP5ViperinmiRNAsmiRNA-17miRNA-20miRNA-28miRNA-29familymembersmiRNA-125bImportantlytreatmentsupernatantactivatedculturesinhibitedreplicationstudiesshowedalsoinduceexpressionISGscellularTetherinAPOBEC3G/3FHIV-infectedfindingsindicatedmightactinfection/replicationHumanIntestinalEpithelialCellsReleaseAntiviralFactorsInhibitInfectionMacrophagesinterferons

Similar Articles

Cited By